Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Jolanta, Miśko"'
Autor:
Jerzy, Zioło, Bogumil, Ramotowski, Beata, Zaborska, Ryszard, Wojdyga, Jolanta, Miśko, Andrzej, Budaj
Publikováno v:
Kardiologia polska.
Autor:
Jerzy Zioło, Bogumil Ramotowski, Beata Zaborska, Ryszard Wojdyga, Jolanta Miśko, Andrzej Budaj
Publikováno v:
Kardiologia Polska. 81:308-309
Autor:
Agata Walęcka-Mazur, Jolanta Miśko, Mirosław Dziuk, Ewa Witkowska-Patena, Agnieszka Giżewska, Anna Budzyńska
Publikováno v:
Prostate Cancer and Prostatic Diseases. 23:343-348
The aim of the study was to prospectively evaluate diagnostic performance of 18F-PSMA-1007 PET/CT in patients with prostate cancer (PCa) after radical treatment and low but rising prostate-specific antigen (PSA) levels. We prospectively enrolled 40 c
Autor:
Grażyna Brzezińska-Rajszys, Magdalena Marczak, Joanna Petryka, Mateusz Śpiewak, Elżbieta Ciara, Lidia Ziółkowska, Katarzyna Bieganowska, Dorota Piekutowska-Abramczuk, Jolanta Miśko, Łukasz Mazurkiewicz, Agnieszka Boruc, Monika Kowalczyk-Domagała
Publikováno v:
Journal of Clinical Medicine
Volume 10
Issue 4
Journal of Clinical Medicine, Vol 10, Iss 650, p 650 (2021)
Volume 10
Issue 4
Journal of Clinical Medicine, Vol 10, Iss 650, p 650 (2021)
Introduction: The most efficient risk stratification algorithms are expected to deliver robust and indefectible identification of high-risk children with hypertrophic cardiomyopathy (HCM). Here we compare algorithms for risk stratification in primary
Autor:
Jolanta Miśko, Agata Walęcka-Mazur, Anna Budzyńska, Ewa Witkowska-Patena, Agnieszka Giżewska, Mirosław Dziuk
Publikováno v:
Clinical nuclear medicine. 44(12)
PURPOSE OF THE REPORT The aim of the study was to prospectively compare performance of F-fluorocholine (FCH) and F-prostate-specific membrane antigen (PSMA)-1007 PET/CT in patients with biochemical relapse (BCR) of prostate cancer and low prostate-sp
Publikováno v:
Clinical nuclear medicine. 44(6)
F-prostate-specific membrane antigen (PSMA) 1007 is one of the most promising radiotracers for PET imaging of relapsing prostate cancer. Minimal urinary clearance seems to be its most valuable and outstanding feature. We present images of biochemical
Autor:
Agata Kubik, B. Sawionek, Łukasz A. Małek, Mateusz Śpiewak, Łukasz Mazurkiewicz, Magdalena Marczak, Agnieszka Dąbrowska, Stefan K. Piechnik, Barbara Miłosz-Wieczorek, Konrad Werys, Rohan S. Wijesurendra, Piotr Bogorodzki, Jolanta Miśko, Ewa Piątkowska-Janko, Joanna Petryka-Mazurkiewicz, Łukasz Błaszczyk
Publikováno v:
Journal of Magnetic Resonance Imaging. 44:1483-1492
PURPOSE To investigate whether magnetic resonance imaging (MRI) cine-derived dyssynchrony indices provide additional information compared to conventional tagged MRI (tMRI) acquisitions in heart failure patients undergoing cardiac resynchronization th
Autor:
Witold Rużyłło, Mateusz Śpiewak, Elżbieta Katarzyna Biernacka, Łukasz A. Małek, Marcin Demkow, Joanna Petryka, Mirosław Kowalski, Jolanta Miśko, Łukasz Mazurkiewicz, Magdalena Marczak, Piotr Hoffman
Publikováno v:
Kardiologia Polska. 72:631-639
Background: Impaired right ventricular (RV) mechanics is a common problem in patients after repair of tetralogy of Fallot (TOF). Moreover, impaired left ventricular (LV) systolic function has also been demonstrated in this population. There are no st
Autor:
Magdalena Marczak, Witold Rużyłło, Łukasz A. Małek, Elżbieta Katarzyna Biernacka, I. Michałowska, Marcin Demkow, Jolanta Miśko, Piotr Hoffman, Mateusz Śpiewak, M. Kowalski
Publikováno v:
Clinical Radiology. 69:e299-e306
To assess the relationship between cardiothoracic ratio (CTR) and ventricular and atrial volumes in patients with repaired tetralogy of Fallot (TOF).Patients with repaired TOF undergoing cardiac magnetic resonance (CMR) and chest radiography within 1
Autor:
Mateusz Śpiewak, Piotr Hoffman, Elżbieta Katarzyna Biernacka, Magdalena Marczak, Jolanta Miśko, Witold Rużyłło, Łukasz A. Małek, Marcin Demkow, Mirosław Kowalski
Publikováno v:
Advances in Interventional Cardiology. 2:104-109
Introduction: In patients with repaired tetralogy of Fallot (TOF), various pathologies of the vascular system (both arterial and venous) may be present as a result of the previous therapeutic procedures or due to the congenital disease itself. Becaus